PD Peritonitis (ISPD)
PD peritonitis is the single most-asked PD case in the viva (the examiner drills diagnosis, exact empiric intraperitoneal antibiotics, duration by organism, and the indications for catheter removal). The examiner waits for three keywords: cloudy effluent, effluent WBC >100 with >50% neutrophils, and intraperitoneal vancomycin + ceftazidime. He will then escalate: fungal? refractory? when do you pull the catheter? Anchor every answer on ISPD 2022.
Watch & listen to this topic
⚡ NephroApp short · 2 min summary
🎧 Full podcast
⚡ NephroApp short · 2 min summary
🎧 Full podcast
Exam links & past questions
🎯 Asked in the real exam · 56 reports — answer each aloud
- PD peritonitis: diagnostic criteria and empirical therapy; culture-negative, improving at day 3 with effluent WBC under 100 — stop both, continue both, or stop the Gram-negative agent? Duration?
- PD peritonitis: diagnostic criteria and treatment.
- PD peritonitis: treatment and indications for PD catheter removal.
- Cloudy effluent in PD: differential diagnosis, diagnostic criteria of peritonitis, antibiotics, antifungal, vancomycin dosing/indication, drain/dwell/instill volumes and repeat culture
- PD exit-site/dressing with discharge fluid + inflammatory mass: differential (calciphylaxis, cancer, granuloma, exit-site/tunnel infection, peritonitis); investigations (what else x3); biopsy and treat calciphylaxis/peritonitis, antiemetics, ultrasound
- Last Thursday Session 2: 100kg ICU patient creat 600, K 6.5, severe acidosis, anuria >6h - CRRT (more convection than diffusion), filter clotted after 6h; peritonitis again; female ER weakness, Na 124 on VBG, euvolemic - diagnosis/urinary findings/treatment; FSGS management; young patient with HTN (radiology/cortisol/TSH/renin-aldosterone normal, K 5, bicarb 18) - diagnosis & management; kidney transplant ABMR on biopsy - treatment step by step (plasmapheresis said no, steroids dose, eculizumab/bortezomib = refer to tertiary).
- PD patient on daily hyperosmotic dextrose dwell, after 3 months presents with abdominal pain and weight loss, no signs of peritonitis - is this EPS?
- Q4: PD patient abdominal pain - peritonitis diagnosis/criteria/ttt
- Full exam recall - Committee 1 (5 cases) and Committee 2 (6 cases)
- Last Thursday's exam: pregnancy in post-transplant; PD peritonitis diagnosis & treatment; UF failure scenario; calciphylaxis scenario; prolonged bleeding AVF; endocarditis patient developing AKI after 1 week (-> PSGN); DM/HTN CKD G3 A2 management; causes of EPO resistance; SIADH criteria; pregnancy in advanced renal failure with diabetic nephropathy needing HD (dialysis prescription); diabetic creat rising 100->200 with NSAID use (NSAID-induced AKI); 23yo hematuria/proteinuria creat 104, 24h protein 1.6g, FSGS - treatment then ESRD - transplant advice; most common cause of abdominal pain in PD patient; renal biopsy precautions to reduce bleeding; ICU hypernatremia and treatment.
- Compiled Qs last Thursday: IgA nephropathy pathology and poor prognostic features; MN treatment; recurrent stones reaching RTA type 1 and treatment; hypokalemia with metabolic alkalosis in young patient (= Liddle); AMR and acute cellular rejection treatment; UF failure in PD; friable erythematous area near peritoneal exit (not peritonitis); evidence-based approaches to decrease CKD progression; hepatorenal syndrome treatment; secondary HTN reaching renal artery stenosis.
- PD questions: DDx of abdominal pain in PD; PET test; UF failure; peritonitis; friable tissue around exit site.
- Friable area bleeding on touch near exit site, no peritonitis, no exit/tunnel infection: approach.
- Peritonitis: diagnosis and treatment, and duration of antibiotics for each organism.
- PD patient 6 months with abdominal pain and fever: approach, diagnose peritonitis, treatment.
- Two stations of recalled cases. Station I: (1) management of focal FSGS (controversial), new drugs; (2) 30y male BP 190/120 c/o headache for 4 months — approach; (3) hyponatremia c/p types & Rx; (4) hypernatremia; (5) 30y male all of sudden Cr 3mg, acute or RPGN — types, causes, presentation, Rx. Station II: (1) CRRT dose, how to calculate, types; (2) PD peritonitis c/p & management, which cephalosporin and how much you give; (3) euvolemic hyponatremia; (4) autosomal dominant ADPKD, age, bleeds, approach → novel drugs, trials, tolvaptan (doses). Hyperkalemia, HTN, metabolic acidosis — which syndrome.
- Patient on CAPD with PD peritonitis — diagnosis and management of PD peritonitis, plus indications for PD catheter removal (ISPD 2022 guideline).
- Handwritten exam topic list (continued): peritonitis Dx/Mgt/organism; rising SCr; rising SCr plus blood urea DDx; myeloma cast and AKI in myeloma.
- Compiled exam topic list across stations and languages: AKI (causes, mechanism, CRRT/SLED, rhabdo, myeloma, sepsis); PD peritonitis Dx/Tx; hyponatremia/SIADH and causes in CKD/cirrhosis; secondary HTN algorithm; MN; lupus pulse steroid; HRS; hyperkalemia algorithm; Bartter/Gitelman/Alport; transplant rejection/donor; HD/PD/UF; renal biopsy precautions; pre-eclampsia; recurrent GN in pregnancy; hypocalcemia/cinacalcet; pedal edema.
- Session 2: ICU septic shock creat 500, K 7, MAP 65 (approach); commercial transplant to ER creat 400 3 days post-transplant; recurrent stones bicarb 14, K 3.2, RTA type 1 (mechanism and treatment); 28yo HTN with hyperkalemia (Gordon-type); peritonitis (diagnosis & detailed treatment, indications for PD catheter removal); CRS type 1 (approach, medical vs UF study).
- Exam set: 33F creat 2.3, BP 145/90, hematuria 2+, proteinuria 2+ (approach & DD); 13M hypokalemia (DD & Bartter management); 70M pneumonia/sepsis/AKI BP 70/40 (CRRT prescription); PD/APKD 6 weeks reduced effluent, catheter OK, clear, no peritonitis (cause? leak/loculated); mild chronic hyponatremia management; elderly female DM 1yr proteinuria, not HTN, normal retina (DD, work up as non-diabetic).
- PD peritonitis management: drain fluid, dwell 2 hours, take sample/culture, empirical intraperitoneal antibiotics (vancomycin + gentamicin or ceftazidime); choice depends on residual renal function
- Committee 1 topics: approach to hyponatremia; solitary unilateral renal mass; AVF malfunction with thrill; workup of stone; nephrotic syndrome in 16yo (treatment of edema); PD outflow/inflow problem with abdominal pain, no peritonitis; ESRD on HD with anemia & hyperparathyroidism (treatment of anemia, doses, no correction, next step); secondary HTN; HTN patient develops proteinuria.
- First session 1: CRRT 100kg patient, reduce clotting risk (high FF); ABMR; peritonitis; lupus nephritis class IV management + cyclophosphamide side effects/prevention (hemorrhagic cystitis); 44y male recurrent renal stone (was RTA type 1); asymptomatic hyponatremia (was SIADH).
- PD peritonitis management per guidelines: how to give antibiotics, route, dwell time, who administers, and what to add besides antibiotics after sending culture
- Committee 1 (long): IDH; abdominal wall friable skin lesion bleeding easily near exit site, no exit-site/tunnel infection or peritonitis - cause & treatment; EPS risk factors & treatment; indication of dialysis in hepatorenal syndrome, modality, prescription (wanted discussion with patient/family that dialysis won't change outcome); CRRT dose & complications + study name and patient number; cause of glomerular hematuria + assessing renal function loss from biopsy in IgA; C3-mediated MPGN causes/diagnosis/treatment; immediate & late complications in kidney donor candidate; treatment of ACR by Banff score; hyponatremia new safe SIADH drugs; treatment of tertiary hyperparathyroidism + surgery complications; CKD progression prevention per guidelines; AKI risk factors in cardiovascular surgery in diabetic with heart failure.
- 45 y/o female PD patient with abdominal pain for ~5 years/episode: differential (is it peritonitis?) and approach to catheter malfunction/outflow obstruction.
- S1Q4: PD peritonitis definition; empiric antibiotics; treat at home or hospital. Q5: investigation of lithiasis (blood and urine).
- S1Q3: Increasing number of PD patients with peritonitis in your unit — why, problems, prevention.
- S2Q6: ESRD HTN on non-dihydropyridine CCB, on PD, cloudy fluid, peritonitis workup normal — what to do, what to suspect.
- PD pt (APKD), on PD 6 weeks, reduced effluent, catheter OK, effluent clear, no peritonitis, all else OK — cause? (leak vs loculated fluid).
- Examiner 1 (classic 'solid medicine' school) rapid-fire one question per branch: PD - peritonitis, exit-site, catheter migration, malfunction, infection (buzzwords expected).
- 25 y/o woman on peritoneal dialysis with hemorrhagic (bloody) effluent / hemoperitoneum: approach.
- Peritonitis diagnosis and treatment; duration of antibiotics for each organism.
- Handwritten study checklist of recalled consultant exam topics, organized by examiner/candidate ('Abou' section, top-left column): peritonitis Dx/Mgt/organism; resistant/secondary HTN initial workup; CRRT prescription; BK virus Dx/Bx/Mgt; hypoNa investigation/Mgt; MN (membranous nephropathy) risk/prognosis/Dx of SHU.
- Study checklist ('Abou' section, top-right column under 'Mgt'): AKI rhabdomyolysis (hyperK, chronic, hyperK) Mgt; HD with 15 yrs of dialysis - beta-2 microglobulin / dialysis (amyloidosis); PD recurrent peritonitis -> EPS (encapsulating peritoneal sclerosis) Mgt; BK virus; secondary HTN algorithm; lupus proteinuria.
- Study checklist ('Angad' section, left column): AKI causes & mechanism / CKD pre-renal & post-renal causes; dialysis modalities CRRT vs SLED; PD peritonitis Tx; HypoNa causes & how to determine the cause; Wegener Tx.
- Study checklist (bottom section, right column): HD pain (filter reaction - DWO); later Tx complications; PD peritonitis Dx + Mgt; DN (diabetic nephropathy) creat 3, antidiabetic drug Mgt; renal transplant cover load, Mgt, Dx, monitor; HUS investigation.
- PD peritonitis: diagnosis, treatment (antibiotics, antifungal?), heparin.
- Peritonitis: PD (indication CGdg management, indication of catheter removal).
- Criteria of peritonitis.
- How to diagnose PD (peritonitis)? Management (antifungal +++, heparin +++).
- Peritonitis: drug dosage and route of administration; indications for PD catheter removal
- Peritonitis: diagnosis and treatment
- Peritonitis scenario: diagnosis and management
- Indications and contraindications of peritoneal dialysis; treatment of peritonitis
- PD peritoneal infection (per ISPD recommendations)
- Peritonitis: diagnosis, management, organisms, indications for catheter removal
- Recurrent peritonitis (EPS?): diagnosis and treatment
- 56yo on APD 1 year with cloudy effluent: approach, diagnosis, diagnostic criteria, treatment
- Peritonitis and indications for PD catheter removal; how to treat peritonitis; ask about antibiotic therapy
- Encapsulating peritonitis (encapsulating peritoneal sclerosis): management
- PD patient presents with abdominal pain + fever + cloudy effluent dialysate: definition of peritonitis (ISPD); management; indications for catheter removal
- Woman 37 years, ESRD on PD, no fever, no abdominal pain, hemorrhagic effluent: causes (gyne/surgical... Pertraite); peritonitis definition/management (ISPD 2022); encapsulating peritonitis definition/management
- PD peritonitis: diagnosis criteria (leucocytosis >100); treatment Gram(+)/Gram(-) (don't forget 3rd generation cephalosporin in Gram(+) protocol). Intradialytic hypotension: causes; management (midodrine +++)
- PD peritonitis: diagnosis and treatment.
🎯 Asked in the real exam · 1 report — answer each aloud
- Indications of peritoneal catheter removal.
PD peritonitis at a glance
Sample before antibiotics, treat IP, know when the catheter comes out.
- Cloudy effluent Peritonitis until proven otherwise.
- Sampling, then IP therapy Culture bottles first, then IP vancomycin + ceftazidime.
- Catheter removal Fungal: now. Refractory: day 5.
-
Stop 1 · Diagnosis
Diagnostic criteria
Any 2 of 3; culture may still be pending.
1Clinical
Abdominal pain and/or cloudy effluent.
2Effluent cell count
WBC >100/µL, >50% neutrophils, dwell ≥2 h.
3Effluent culture
Positive.
Dry abdomen
Instill ~1 L, dwell 2 h, drain and sample.
Rapid-cycle APD
>50% neutrophils strongly suggests peritonitis, even if WBC <100/µL.
Memory hook“Cloud, Count, Culture: any two.”
Exam trapEosinophils: chemical peritonitis (icodextrin, solution or tubing).
Red cells: haemoperitoneum (menstruation, ovulation).
Pain alone: constipation, catheter malposition. -
Stop 2 · Investigations
Diagnostic sampling
Count, differential, Gram stain, culture before antibiotics; then treat at once.
BedsideBlood-culture bottles
5–10 mL into aerobic and anaerobic.
Lab within 6 h; delayed: 37 °C. Never refrigerate or freeze.Higher yieldCentrifugation
50 mL, 3000 g, 15 min; pellet in 3–5 mL supernatant.
Yield rises 5–10 fold.Blood cultures if septic or immunosuppressed; swab exit-site discharge.
Unit targetCulture-negative <15% of episodes (specialised centres <10%); above it, review technique.
-
Stop 3 · Treatment
Empirical antibiotic therapy
Gram-positive and Gram-negative cover, IP; unit antibiogram decides.
- Gram-positive IP vancomycin
- CAPD 15–30 mg/kg every 5–7 days
APD 15 mg/kg every 4 days - No universal trough target.
- Gram-negative IP ceftazidime
- Long dwell 1–1.5 g once daily
Short dwell 20 mg/kg once daily - Alternatives: gentamicin 0.6 mg/kg daily (short courses; ototoxicity) or cefepime alone.
- Add-on · ISPD 1B Antifungal shield
- Oral nystatin 500,000 units four times daily or fluconazole 200 mg every 48 h, with any antibiotic course.
- Add-on · consider IP heparin
- 500 units/L for cloudy effluent (fibrin occlusion). Analgesics as needed.
Treat at homeStable, trained patient; IP antibiotics.
AdmitFever, sepsis, significant pain, or unable to do PD at home.
Sepsis/hypotension: resuscitate + systemic antibiotics.Memory hookVGram + CGram − IProute 6 hdwell +FantifungalExam trap: IV antibiotics in uncomplicated PD peritonitis.
-
Stop 4 · Tailoring
Organism-specific therapy and duration
Duration follows the organism’s virulence.
2 weeks
Coagulase-negative staphylococci and streptococci.
3 weeks
S. aureus, Pseudomonas, enterococci, Gram-negatives (enteric: at least 3 weeks).
- Pseudomonas: two antipseudomonal drugs, different mechanisms, by sensitivity.
- S. aureus: seek an exit-site or tunnel source.
- Multiple Gram-positives: touch contamination.
- Multiple Gram-negatives/mixed: intra-abdominal source; urgent surgical review + metronidazole.
Culture-negative peritonitis
72 h Repeat count + differential; special cultures (mycobacteria, Nocardia, fungi)
ClearingStop Gram-negative agent; Gram-positive alone, 2 weeks total.
Not clearingSeek fungi/TB. Sterile, no improvement after day 5: remove; antibiotics ≥14 days after.
Exam trapNo extra week “to be safe”: more repeat peritonitis (15.0% vs 5.5%), more fungal risk.
-
Stop 5 · Escalation
Indications for catheter removal
Failure to clear: remove the catheter, not more antibiotics.
- Fungal · immediate
- Yeast or Candida: remove now; oral/IV antifungal ≥2 weeks after removal.
PD resumed in under one-third, median 15 weeks. - Refractory · day 5
- Cloudy or WBC >100/µL after 5 days: remove, unless clearly falling.
- Catheter infection
- Pseudomonas + exit-site and tunnel infection: remove.
S. aureus + exit-site/tunnel infection: consider.
Same-organism exit-site/tunnel infection: suggested (ISPD 2023). - Enteric · urgent
- Faecal or mixed enteric: surgical review + metronidazole.
Remove if laparotomy finds pathology or abscess. - Mycobacterial
- Non-tuberculous: removal suggested (2D). TB: anti-TB drugs, not removal.
Memory hook“Fungus fast, refractory at five.”
-
Stop 6 · Classification
Relapsing, recurrent and repeat peritonitis
4 weeks from the last day of antibiotics, not diagnosis.
RelapsingSame organism (or one sterile episode) within 4 weeks.
RecurrentDifferent organism within 4 weeks; worse prognosis.
RepeatSame organism after more than 4 weeks.
Catheter-related: within 3 months of exit-site/tunnel infection, same organism (or one site sterile on antibiotics).
Timely catheter removal
Consider for relapsing, recurrent or repeat.
Simultaneous removal and reinsertion
Only if culture negative, WBC <100/µL, no exit-site/tunnel infection; perioperative antibiotics.
Mainly staphylococcal relapse; enteric/Pseudomonas: remove, reinsert later.Memory hookSame-soon = relapsing · Different-soon = recurrent · Same-late = repeat.
Long termRecurrent peritonitis + UF failure + bowel symptoms: EPS. Stop PD, move to HD.
-
Stop 7 · Prevention
Wet and dry contamination
Classify first: it decides antibiotics.
Dry contamination
Closed system (distal to a closed clamp).
Reassure, retrain, observe. No antibiotics.Wet contamination
Fluid infused, or set left open.
Change transfer set; effluent count + culture.
Prophylaxis (2D): one IP cefazolin dose reasonable.Peritonitis followed only wet contamination (5.6%); prophylaxis cut risk.
Memory hook“Not sure the clamp was shut? Call it wet.”
Rapid recall
Diagnostic criteria?
2 of 3: pain/cloudy effluent; WBC >100/µL, >50% neutrophils (≥2 h dwell); positive culture.
Effluent sampling?
5–10 mL into aerobic + anaerobic bottles, before antibiotics; lab within 6 h.
Empiric regimen and route?
IP vancomycin + ceftazidime, dwell ≥6 h, plus antifungal prophylaxis.
IP vancomycin dose?
CAPD 15–30 mg/kg every 5–7 days; APD 15 mg/kg every 4 days.
Duration by organism?
2 weeks CoNS/strep; 3 weeks S. aureus, Pseudomonas, enterococci, Gram-negatives.
Culture-negative at 72 h, clearing?
Stop Gram-negative agent; Gram-positive agent alone, 2 weeks total.
Refractory peritonitis?
Cloudy or WBC >100/µL after 5 days of appropriate antibiotics: remove catheter.
Fungal peritonitis?
Remove catheter now; systemic antifungal ≥2 weeks after removal.
Relapsing vs recurrent?
Same vs different organism, within 4 weeks of the last antibiotic day.
Wet contamination?
Change transfer set, effluent count + culture, prophylaxis (one IP cefazolin dose reasonable).
Next tabs: detail, spoken answer, viva questions.
Sources: ISPD peritonitis 2022 update (Li et al.); ISPD 2023 catheter-related infection.
📋
Case scenarios
Cases reported from real exam sittings.
Case scenarios
Cases reported from real exam sittings.Step 1 — classify. Ask exactly what happened. DRY = the system stayed closed (disconnection distal to a closed clamp, no dialysate contact). WET = open system: fluid was infused after the contamination, or the catheter administration set was left open for a prolonged period. Examples of wet: leak from the dialysate bag, a leak or break in the tubing proximal to the clamp, breach of aseptic technique or touch contamination of the connection during an exchange. If the patient cannot confirm the clamp was shut, call it wet (ISPD 2022, benefit of the doubt).
Step 2 — if DRY: no prophylactic antibiotics. Reassure, review and retrain the exchange technique, and tell the patient to report pain, fever or cloudy fluid immediately.
Step 3 — if WET: (i) bring the patient in and change the sterile transfer set; (ii) send PD effluent for cell count with differential and culture even if asymptomatic; (iii) give prophylactic antibiotics — ISPD 2022 (2D) recommends prophylaxis after wet contamination but states there is no standard regimen; one dose of intraperitoneal cefazolin is a reasonable option. A short oral fluoroquinolone course was used historically but is now FDA-discouraged unless no alternative exists.
Step 4 — follow-up. Monitor closely for an extended period (a broader organism spectrum may follow, particularly in tropical centres). If any symptom appears, sample the effluent and start empiric IP antibiotics at once, without waiting for the results.
Step 5 — root cause. Audit the exchange technique, hand hygiene, the environment and the connectology; retrain, and log the event in the unit’s peritonitis-prevention audit.
Evidence to quote: in a series of 548 touch-contamination episodes cited by ISPD 2022, peritonitis occurred in 3.1% overall and only after wet contamination (5.6%), mostly coagulase-negative staphylococcal or culture-negative, and the risk fell significantly with prophylactic antibiotics.
Definition first: culture-negative peritonitis = the diagnostic criteria are met (abdominal pain and/or cloudy effluent + effluent WBC >100/uL with >50% neutrophils) but no organism is identified on effluent culture. If the source is clearly enteric, ISPD 2022 says classify it as enteric peritonitis, not culture-negative.
Ask why: recent antibiotic exposure, suboptimal sample collection or culture method, or a slow-growing atypical organism (mycobacteria, fungus). Non-infectious mimics: eosinophilic or chemical (icodextrin) peritonitis — check the differential. Hemoperitoneum is not peritonitis.
Fix the technique: inoculate 5–10 mL effluent at the bedside into both aerobic and anaerobic blood-culture bottles; for higher yield centrifuge 50 mL at 3000 g for 15 min and culture the pellet resuspended in 3–5 mL supernatant (5–10 fold yield increase); deliver within 6 h, incubate at 37°C if delayed, never refrigerate or freeze. ISPD target: culture-negative under 15% of all episodes (2C: review sampling and culture methods if above that); specialised centres achieve under 10%.
Day-3 algorithm: if there is no growth at 72 h, repeat the effluent cell count with differential and send a special culture request for mycobacteria, Nocardia, filamentous fungi and other fastidious bacteria; subculture on aerobic, anaerobic and microaerophilic media for a further 3–4 days. If improving → stop the Gram-negative agent and continue the Gram-positive agent alone (ISPD: the initial therapy is continued; Figure 10 example: stop gentamicin, continue cefazolin IP); total duration 2 weeks (outcomes at 2 and 3 weeks were similar). If not improving → special cultures and a search for fungi or mycobacteria; if still sterile with no improvement after day 5, remove the catheter and continue antibiotics for at least 14 days after removal (removal is required in about 10% of culture-negative episodes). Cure with antibiotics alone is 67.5–82.3%.
🎓
Viva Q&A
Key points from this topic, framed as questions you could be asked in the viva.
tap to reveal · self-test
Viva Q&A
Key points from this topic, framed as questions you could be asked in the viva.Q1What are the diagnostic criteria for PD peritonitis?reveal
Q2The abdomen is dry (no dwell) — how do you exclude peritonitis?reveal
Q3What empiric antibiotics do you start, and by which route?reveal
Q4What do you add besides antibiotics?reveal
Q5What is the vancomycin dose in PD peritonitis?reveal
Q6How long do you treat, by organism?reveal
Q7When do you remove the PD catheter?reveal
Q8Yeast is seen on Gram stain — what now?reveal
Q9Why does ISPD 2022 recommend antifungal prophylaxis?reveal
Q10A PD patient has abdominal pain but clear effluent and normal cell count — is this peritonitis?reveal
Q11Why increasing peritonitis rates in your unit, and how do you prevent it?reveal
Q12Recurrent peritonitis over several years with UF failure and bowel symptoms — what do you fear?reveal
Q13Define recurrent, relapsing, repeat, refractory and catheter-related peritonitis (ISPD 2022).reveal
RELAPSING: an episode within 4 weeks of completing therapy with the SAME organism, or where one of the two episodes is sterile (culture-negative).
RECURRENT: an episode within 4 weeks of completing therapy with a DIFFERENT organism — worse prognosis than relapsing.
REPEAT: an episode MORE than 4 weeks after completing therapy with the SAME organism.
REFRACTORY: persistently cloudy bags or effluent leukocyte count above 0.1 x10^9/L (>100/uL) after 5 days of appropriate antibiotics.
CATHETER-RELATED: peritonitis occurring in temporal conjunction — within 3 months — with an exit-site or tunnel infection, with the same organism at both sites, or one site sterile in the context of antibiotic exposure.
Relapsing, recurrent and repeat episodes all warrant consideration of timely catheter removal (1C).
Q14A patient phones after a break in sterile technique during an exchange — take me through it A to Z.reveal
DRY contamination = contamination outside a closed system, e.g. a disconnection distal to a closed clamp.
WET contamination = an open system: dialysis fluid was infused after the contamination, or the administration set was left open for a prolonged period — for example a leak from the bag, a leak or break in the tubing proximal to the clamp, or touch contamination of the connection. If I cannot confirm the clamp was closed, I call it wet.
Dry: no antibiotics — reassure, retrain the technique, ask them to report pain, fever or cloudy fluid.
Wet: bring the patient in, change the sterile transfer set, send effluent for cell count with differential and culture even if asymptomatic, and give prophylactic antibiotics — ISPD 2022 (2D) recommends prophylaxis after wet contamination but states there is no standard regimen; one dose of intraperitoneal cefazolin is a reasonable option (oral fluoroquinolones are now FDA-discouraged). Then monitor closely for an extended period and audit the exchange technique. In the 548-episode series ISPD cites, peritonitis followed only wet contamination — 5.6%, versus 3.1% overall — and prophylactic antibiotics significantly reduced it.
Q15Does DRY contamination need prophylactic antibiotics?reveal
Q16The cultures come back negative — what do you do?reveal
If the effluent is clearing the organism was probably Gram-positive: I stop the Gram-negative agent and continue the Gram-positive agent alone (ISPD: the initial therapy is continued; Figure 10 example: stop gentamicin, continue cefazolin IP for 14 days) for a total of 2 weeks — 3 weeks gives no better outcome.
If it is not improving I send special cultures and look for fungi or mycobacteria; if it is still sterile with no improvement after day 5, I remove the catheter and continue antibiotics for at least 14 days after removal. Removal is needed in about 10% of culture-negative episodes.
I also exclude non-infectious mimics — eosinophilic or icodextrin-related chemical peritonitis — on the differential.
Q17What is an acceptable culture-negative rate and how do you reduce it?reveal
To reduce it: inoculate
- 5-10 mL of effluent at the bedside into both aerobic and anaerobic blood-culture bottles
- for higher yield centrifuge 50 mL at 3000 g for 15 minutes and culture the pellet resuspended in 3-5 mL of supernatant, which raises the yield 5-10 fold
- get the specimen to the laboratory within 6 hours, incubate at 37 C if delayed, and never refrigerate or freeze the bottles.
Q18When can you replace the catheter in relapsing peritonitis instead of transferring to HD?reveal
Q19A relapsing episode grows S. aureus, or enterococci or a Gram-negative. What do you look for besides removing the catheter?reveal
Coagulase-negative staphylococci form biofilm on the catheter, which is why they can relapse.
Q20The effluent white count is high but eosinophils predominate and the culture is negative. What is it and what do you do?reveal
Q21A PD patient is booked for a colonoscopy or hysteroscopy. How do you protect against peritonitis?reveal
Q22A PD patient on a calcium channel blocker has cloudy effluent, but the peritonitis work-up is normal (effluent WBC below 100/uL, culture negative). What do you suspect and what do you do?reveal
Chylous effluent is the key suspect: chylomicrons make the fluid cloudy, and calcium channel blockers are a recognised cause (the Handbook lists dihydropyridine blockers among the causes of turbid fluid). I send the effluent for triglycerides, cell differential (eosinophils) and cytology, and I check the sample was not taken from a dry abdomen or full of fibrin.
If it is chylous I review the drug and consider changing the antihypertensive, and I look for other causes of sterile cloudy effluent: lymphatic obstruction, acute pancreatitis, lymphoma or other malignancy.
Q23Give five measures that prevent PD peritonitis.reveal
2) Connection technique: in CAPD, a disconnect system with a flush-before-fill design (1A), since touch contamination of the connection is the commonest cause.
3) Catheter insertion: systemic antibiotic prophylaxis immediately before insertion.
4) Exit site: daily topical antibiotic at the exit site (gentamicin 0.1% cream is the one the Handbook names; mupirocin is the other option) and prompt treatment of any exit-site infection.
5) Cover for procedures: antibiotic prophylaxis before colonoscopy and invasive gynaecological procedures.
I add oral nystatin or fluconazole whenever an antibiotic course is given, give prophylactic antibiotics after wet contamination, and treat constipation. I audit the unit's peritonitis rate against ISPD targets.
Q24How do you diagnose eosinophilic (allergic) PD peritonitis and what is the empirical treatment?reveal
The Handbook lists it among the causes of turbid fluid and says it may be an allergic reaction to the PD solution or tubing. Because I cannot separate it from bacterial peritonitis at presentation, I sample and start the standard empirical intraperitoneal antibiotics. If the effluent does not clear I resend for special cultures (fungi, mycobacteria, virus) and consider other causes: an allergic reaction to the dialysate (icodextrin) or a drug, or malignancy or lymphoproliferative disease.
Catheter-removal indications are the same as for any peritonitis: refractory, fungal, faecal needing laparotomy, or (suggested) non-tuberculous mycobacterial, with timely removal considered for relapsing episodes.
Spoken approach
say this aloud- Opening: This is a PD patient with abdominal pain, fever and cloudy effluent; my priority is to sample the effluent before antibiotics and treat it as peritonitis until proven otherwise.
- Stabilise: I check vital signs for sepsis; I admit if there is fever, sepsis, significant pain or the patient cannot do PD at home; otherwise a stable, trained patient is treated at home. Antibiotics go intraperitoneally unless there are features of systemic sepsis.
- History: I ask about abdominal pain, fever, exit-site or tunnel changes, recent connection breaks, constipation and diarrhoea.
- Examination: I examine the abdomen, and the exit site and tunnel for a source.
- Labs: I drain the dwell and send cell count with differential, Gram stain and culture in blood-culture bottles before antibiotics; blood cultures if septic or immunosuppressed. If the abdomen is dry, I instill about 1 L, dwell 2 hours, then drain and sample.
- Imaging & specific tests: I inoculate 5-10 mL into aerobic and anaerobic bottles at the bedside, to the lab within 6 hours; for higher yield I centrifuge 50 mL at 3000 g for 15 minutes and culture the pellet.
- Diagnosis: I need 2 of 3: abdominal pain and/or cloudy effluent, effluent WBC above 100/uL with more than 50% neutrophils after at least a 2-hour dwell, positive culture. The culture may be pending, so the first two are enough — only now do I say peritonitis.
- Treatment: Straight after sampling, intraperitoneal vancomycin plus ceftazidime, dwell at least 6 hours: vancomycin 15-30 mg/kg every 5-7 days in CAPD, 15 mg/kg every 4 days in APD; ceftazidime 1-1.5 g once daily in a long dwell. Once-daily gentamicin is an alternative Gram-negative agent; the unit antibiogram decides.
- Treatment — adjuncts: consider IP heparin 500 units/L for cloudy effluent (may help prevent fibrin occlusion of the catheter), analgesics as needed, and antifungal prophylaxis with oral nystatin or fluconazole during any antibiotic course (ISPD 2022).
- Treatment — duration: I tailor to culture: 2 weeks for coagulase-negative staph and streptococci; 3 weeks for S. aureus, Pseudomonas, enterococci and Gram-negatives. I do not extend to be safe — one extra week gave more repeat peritonitis, and longer courses raise the fungal risk.
- Treatment — culture-negative: At 72 hours with no growth I repeat the cell count with differential and request special cultures for mycobacteria, Nocardia and fungi. If clearing, I stop the Gram-negative agent and continue the Gram-positive agent alone, 2 weeks in total (ISPD Figure 10 example: stop gentamicin, continue cefazolin IP for 14 days); if still sterile with no improvement after day 5, I remove the catheter and continue antibiotics for at least 14 days after removal.
- If it fails: Still cloudy or effluent WBC above 100/uL at 5 days is refractory, so I remove the catheter, unless the count is clearly falling toward normal. Fungal means remove immediately with systemic antifungal for at least 2 weeks after removal. For non-tuberculous mycobacteria ISPD suggests removal (2D), but TB is treated with anti-TB drugs instead; faecal peritonitis needs surgical review.
- If it fails — replacement: For relapsing, recurrent or repeat peritonitis I consider timely catheter removal; simultaneous removal and reinsertion only once culture is negative, WBC below 100/uL and there is no exit-site or tunnel infection; this single-stage option is mainly for Staphylococcal relapse, while after enteric or Pseudomonas relapse I remove first and reinsert later.
- Classification: The clock runs from the last day of antibiotics. Relapsing: same organism, or one sterile episode, within 4 weeks; recurrent: different organism within 4 weeks; repeat: same organism after more than 4 weeks.
- Classification — catheter-related: Catheter-related means within 3 months of an exit-site or tunnel infection, same organism or one site sterile on antibiotics.
- Contamination call: If a patient phones after a break, I classify first. Dry means the system stayed closed: reassure, retrain, no antibiotics. Wet means fluid infused or the set left open, and if unsure I call it wet.
- Contamination call — wet: I change the sterile transfer set, send effluent cell count and culture, and give prophylactic antibiotics — ISPD 2022 has no standard regimen; one IP cefazolin dose is reasonable — then monitor closely.
- Follow-up: I find the root cause — touch contamination, exit-site infection, constipation — and reinforce prevention; the culture-negative target is under 15% of episodes. Recurrent peritonitis over years with UF failure and bowel symptoms raises EPS: stop PD and move to HD.
Escalation ladder
and if that fails?Cloudy effluent → sample → empiric IP vancomycin + ceftazidime + antifungal prophylaxis + consider IP heparin → tailor to culture.
And if it fails? Still cloudy or effluent WBC >100/uL at 5 days = refractory → remove the catheter (do not persist with antibiotics; longer observation only if the count is clearly falling toward normal). Fungal (yeast on Gram stain) → remove now + systemic antifungal for at least 2 weeks after catheter removal; in fungal peritonitis PD was resumed after a median of 15 weeks, in under one-third of cases (ISPD 2022), with the timing individual after resolution. Relapsing, recurrent or repeat → consider timely removal; simultaneous replacement only once the culture is negative and the WBC is <100/uL (mainly for Staphylococcal relapse; after enteric or Pseudomonas relapse remove first and reinsert later). Fecal/enteric → urgent surgical review + anaerobic cover (metronidazole); the catheter is usually removed if laparotomy is needed. TB → anti-TB drugs, not removal; non-tuberculous mycobacteria → antibiotics + removal (suggested, 2D).
Recurrent peritonitis over years → think EPS (bloody/turbid effluent, UF failure, bowel obstruction) → stop PD, switch to HD, nutrition, +/- tamoxifen/steroids (evidence anecdotal).
Cultures still sterile at 72 h? Do not just carry on. Repeat effluent cell count with differential and request special cultures (mycobacteria, Nocardia, filamentous fungi, other fastidious bacteria); subculture aerobic/anaerobic/microaerophilic for a further 3–4 days. Effluent clearing → stop the Gram-negative agent, continue the Gram-positive agent alone, total 2 weeks (3 weeks adds nothing). Not improving → special cultures; still sterile with no improvement after day 5 → remove the catheter and continue antibiotics for at least 14 days after removal (removal is needed in about 10% of culture-negative episodes). ISPD 2022 reports ampicillin–sulbactam plus amikacin as a salvage regimen in a small series.
Contamination call, not peritonitis? Classify first. DRY (system stayed closed, break distal to a closed clamp) → reassure, retrain, observe — no antibiotics. WET (fluid infused after the break, or the set left open; or you cannot confirm the clamp was shut) → change the sterile transfer set + send effluent cell count and culture + prophylactic antibiotics (ISPD 2022, 2D; one IP cefazolin dose is reasonable) → monitor closely for an extended period.
💊
Management
Diagnose and start empiric IP antibiotics
- 2 of 3: abdominal pain and/or cloudy effluent; effluent WBC >100/uL with >50% PMN (dwell >=2 h); positive culture
- Dry abdomen: instill ~1 L, dwell 2 h, drain and sample
- Send cell count/differential, Gram stain, culture BEFORE antibiotics, then start antibiotics at once without waiting for results
- Vancomycin (Gram-positive) + ceftazidime (Gram-negative), intraperitoneal, dwell >=6 h
- Vancomycin IP 15-30 mg/kg every 5-7 days (CAPD) or 15 mg/kg every 4 days (APD), no universal trough target; ceftazidime 1000-1500 mg once daily (long dwell) or 20 mg/kg daily (short dwell)
- Gentamicin 0.6 mg/kg once daily is an accepted alternative Gram-negative agent (ISPD: third-generation cephalosporin or aminoglycoside) (short courses do not speed loss of residual function); avoid prolonged courses (ototoxicity). The unit antibiogram decides; cefepime alone is another option
- Add antifungal prophylaxis (nystatin/fluconazole); consider IP heparin 500 U/L for cloudy effluent (may help prevent fibrin occlusion)
Tailor by culture, duration and removal
- Coagulase-negative staph / streptococci: 2 weeks
- S. aureus, Pseudomonas, enterococci, Gram-negatives: 3 weeks
- Enteric Gram-negative: at least 3 weeks. Polymicrobial: multiple Gram-positive organisms → treat by sensitivities for at least 3 weeks and think touch contamination; multiple Gram-negative or mixed organisms → think intra-abdominal source, urgent surgical assessment, add metronidazole, at least 3 weeks; remove the catheter if laparotomy shows intra-abdominal pathology or abscess
- Culture-negative improving: stop the Gram-negative agent, continue the Gram-positive agent already running alone (ISPD: the initial therapy is continued; Figure 10 example: stop gentamicin, continue cefazolin IP for 14 days) to 2 weeks in total; not improving -> hunt fungi/TB
- Do NOT extend beyond the ISPD duration 'to be safe' — an RCT of one extra week showed no reduction in relapsing/recurrent peritonitis and more repeat peritonitis; prolonged antibiotics also raise the risk of secondary fungal peritonitis
- Pseudomonas: two antipseudomonal antibiotics with different mechanisms, chosen by sensitivity, for 3 weeks; Stenotrophomonas: trimethoprim-sulfamethoxazole-based, two different classes of antibiotics, for at least 3 weeks; after S. aureus peritonitis, look for an exit-site or tunnel source
- Refractory: still cloudy or effluent WBC >100/uL after 5 days of appropriate antibiotics (longer observation acceptable if the count is clearly falling)
- Relapsing (same organism within 4 weeks) / recurrent — consider timely removal
- Fungal peritonitis — remove immediately
- Fecal/enteric peritonitis needing laparotomy (low threshold to remove for enteric Gram-negatives resistant to cephalosporins or fluoroquinolones); non-tuberculous mycobacteria (ISPD suggests removal, 2D; TB is treated with anti-TB drugs instead of removal); exit-site/tunnel infection that progresses to, or occurs with, peritonitis from the same organism (ISPD 2023 suggests removal, 2C)
- Relapsing, recurrent OR repeat peritonitis — consider timely catheter removal (ISPD 2022, 1C)
- Simultaneous removal and reinsertion is an option only once the effluent culture is negative, effluent WBC is below 100/uL and there is no exit-site or tunnel infection (2C), under perioperative antibiotic cover; single-stage replacement is mainly for Staphylococcal relapse, whereas after enteric or Pseudomonas relapse remove first and reinsert later
- Culture-negative peritonitis still not improving after day 5 — remove and continue antibiotics for at least 14 days after removal; about 10% of all culture-negative episodes need removal
- Pseudomonas peritonitis with a concomitant exit-site and tunnel infection: remove the catheter (ISPD 2022, 2D); S. aureus peritonitis with an exit-site or tunnel infection: consider removal
- Other indications: mechanical catheter failure (malposition, fibrin, adhesions or loculation) when conservative steps fail (laxatives or enemas, saline flush or fibrinolytic, surgical repositioning or lysis of adhesions, eventually catheter replacement); isolated exit-site or tunnel infection that fails antibiotics → simultaneous replacement at a new exit site, or surgical salvage (cuff shaving) in selected patients; ISPD 2023 (1C): avoid simultaneous removal and reinsertion when there is deep Dacron cuff involvement or concurrent peritonitis; for catheter infection with concurrent peritonitis, ISPD 2023 advises temporary haemodialysis with no reinsertion until at least 2 weeks after catheter removal and complete resolution of peritonitis
| Agent | Role | Dose / route |
|---|---|---|
| Vancomycin | Empiric Gram-positive | Intermittent IP: 15-30 mg/kg every 5-7 days (CAPD); 15 mg/kg every 4 days (APD); dwell ≥6 h; ISPD 2022 sets no universal trough target |
| Ceftazidime | Empiric Gram-negative | Intermittent IP: 1000-1500 mg once daily (long dwell) or 20 mg/kg once daily (short dwell) |
| Gentamicin | Alternative Gram-negative | 0.6 mg/kg IP once daily; continuous dosing not advised; avoid prolonged courses (ototoxicity) |
| IP heparin | Consider for cloudy effluent: may help prevent fibrin occlusion of the catheter | 500 units/L in each bag |
| Antifungal prophylaxis | Prevent fungal peritonitis (ISPD 2022) | Oral nystatin 500,000 units four times daily, or fluconazole 200 mg every 48 h, during any antibiotic course |
| Fluconazole/echinocandin | Fungal peritonitis (+ remove catheter) | Oral or IV antifungal (oral/IV preferred; IP dosing exists but is not preferred) ≥ 2 weeks after catheter removal |
| Cefazolin | Prophylaxis after WET contamination (ISPD 2022, 2D) | One intraperitoneal dose is a reasonable option — ISPD states there is no standard regimen; oral fluoroquinolones were used previously but are now FDA-discouraged |
| Ampicillin–sulbactam + amikacin | Reported salvage for culture-negative peritonitis with a suboptimal initial response | Small series only (response in 8 of 10 cases) — cited by ISPD 2022, not a graded recommendation |
Quick reference
numbers at a glance| Diagnosis | 2 of 3: pain and/or cloudy fluid, WBC >100 (>50% PMN, dwell ≥2 h), positive culture |
| Dry abdomen | Instill ~1 L, dwell 2 h, drain and sample |
| Empiric IP | Vancomycin + ceftazidime (or once-daily gentamicin; the unit antibiogram decides) |
| Vancomycin | 15-30 mg/kg IP every 5-7 d (CAPD); 15 mg/kg every 4 d (APD) |
| Adjuncts | Consider IP heparin 500 U/L, antifungal prophylaxis (ISPD 2022), analgesics as needed |
| Duration | 2 wk CoNS/strep; 3 wk S. aureus/Pseudomonas/enterococci/GNB |
| Remove catheter | Refractory (5 d), fungal; ISPD suggests removal (2D) for non-tuberculous mycobacteria and (2C) for exit-site/tunnel infection with same-organism peritonitis; consider for relapsing/recurrent/repeat; TB = anti-TB drugs, not removal |
| Fungal | Remove now + antifungal ≥2 wk after removal; PD resumed after a median of 15 wk in under one-third of cases (ISPD 2022), timing individual after resolution |
| Relapsing | Same organism (or one sterile episode) within 4 wk of the LAST antibiotic dose |
| Recurrent | Different organism within 4 wk of the last dose — worse prognosis |
| Repeat | Same organism more than 4 wk after the last dose |
| Refractory | Still cloudy / effluent WBC >100/uL after 5 days of appropriate antibiotics |
| Catheter-related | Within 3 months of an exit-site/tunnel infection, same organism (or one site sterile) |
| Re-insertion | Simultaneous removal + reinsertion once culture negative, WBC <100/uL, no ESI/tunnel infection |
| Dry contamination | Closed system → no antibiotics, retrain, observe |
| Wet contamination | Open system / fluid infused / unsure → transfer-set change + effluent culture + prophylaxis (1 IP cefazolin dose) |
| Culture-negative | Target <15% of episodes; 5–10 mL into aerobic + anaerobic bottles; centrifuge 50 mL at 3000 g x 15 min |
| Day 3, no growth | Repeat cell count + special cultures (TB, Nocardia, fungi); improving → stop Gram-negative agent, Gram-positive alone, 2 wk total; still sterile and not improving after day 5 → remove + antibiotics at least 14 d after removal |
⚑
Red flags
must not miss
- Yeast on Gram stain / Candida — remove the catheter immediately, do not wait
- Fecal odour or multiple enteric organisms — suspect bowel perforation; urgent surgical review
- No improvement (persistently cloudy, high WBC) at day 5 — refractory; remove catheter
- Systemic sepsis / hypotension — resuscitate, add systemic antibiotics, admit
- Recurrent peritonitis over years with UF failure and GI symptoms — EPS
- Patient reports a WET contamination (fluid infused after the break, or the set left open) — transfer-set change plus prophylactic antibiotics and an effluent sample; do not just reassure over the phone
- Clamp status uncertain during a contamination — treat as wet, for the benefit of the doubt (ISPD 2022)
- Unit culture-negative rate above 15% of episodes — review sampling and culture technique (and recent antibiotic use): treatable organisms may be missed
- Second episode with the SAME organism within 4 weeks of finishing antibiotics — relapsing peritonitis; consider timely catheter removal rather than another antibiotic course
🧭
Flowchart
memorize this
graph TD;
A["PD patient, cloudy effluent or abdominal pain"] --> B{"Abdomen has a dwell?"};
B -->|No, dry| C["Instill ~1 L, dwell 2 h, then drain"];
B -->|Yes| D["Drain and sample"];
C --> D;
D --> E["Cell count, Gram stain, culture"];
E --> G["Start empiric IP vancomycin + ceftazidime at once, add antifungal prophylaxis, consider IP heparin"];
G --> F{"2 of 3 criteria confirmed?"};
F -->|"No: clear fluid, normal count, culture negative"| N["Stop antibiotics, consider constipation, catheter malfunction, leak or loculated fluid"];
F -->|Yes| H{"Culture result"};
H -->|Yeast/fungal| I["Remove catheter now + antifungal at least 2 weeks after removal"];
H -->|Bacterial| J["Tailor antibiotics, duration by organism (2 or 3 weeks)"];
J --> K{"Clear by day 5?"};
K -->|No, WBC not falling| L["Refractory, remove catheter"];
K -->|Yes| M["Complete course, review source and prevention"];
H -->|No growth at day 3| O["Repeat cell count with differential, special cultures for mycobacteria, Nocardia, fungi"];
O --> P{"Clinical improvement?"};
P -->|Yes| Q["Stop the Gram-negative agent, Gram-positive agent alone, total 2 weeks"];
P -->|No, still sterile after day 5| L2["Remove catheter, antibiotics at least 14 days after removal"];
R["Contamination during an exchange, no symptoms yet"] --> S{"Wet or dry contamination?"};
S -->|Dry, system stayed closed| T["No prophylactic antibiotics, retrain technique, observe"];
S -->|Wet, or clamp status unknown| U["Change the sterile transfer set, send effluent cell count and culture, one IP cefazolin dose"];
U --> V["Monitor closely, if pain, fever or cloudy fluid appear, sample and start empiric IP antibiotics"];
◈
Exam traps & pitfalls
where marks are lost
- Giving antibiotics IV instead of intraperitoneal for uncomplicated PD peritonitis
- Starting antibiotics before sending cell count, Gram stain and culture
- Giving prolonged aminoglycoside courses (ototoxicity) — a short once-daily gentamicin course is acceptable and does not speed loss of residual function
- Forgetting antifungal prophylaxis (ISPD 2022) and the antifungal-plus-removal rule for fungal peritonitis
- Persisting with antibiotics in refractory peritonitis instead of removing the catheter at day 5
- Calling every abdominal pain 'peritonitis' — missing constipation or catheter malfunction
- Treating every contamination call the same — dry contamination needs no antibiotics; wet contamination needs a transfer-set change, an effluent sample and prophylaxis
- Calling an episode 'recurrent' when the organism is the same — that is relapsing; recurrent means a DIFFERENT organism within 4 weeks
- Dating the 4-week window from the day of diagnosis instead of the last day of antibiotics
- Accepting a high culture-negative rate as bad luck instead of auditing sample volume, blood-culture bottles, centrifugation and transport time
- Extending antibiotics an extra week 'to be safe' — no benefit, more repeat peritonitis, and a higher fungal risk
- Attempting simultaneous catheter removal and reinsertion before the effluent culture is negative and the WBC is below 100/uL
- Relying on intraperitoneal antifungal salvage for fungal peritonitis - the catheter comes out and the antifungal is oral or intravenous (oral/IV preferred; IP dosing exists but is not preferred)
- Removing the catheter for tuberculous peritonitis — TB is treated with anti-TB drugs; catheter removal is suggested for non-tuberculous mycobacteria
🔬
Differential
Cloudy effluent — infectious
- Bacterial peritonitis (Gram-positive: coagulase-negative staph, S. aureus; Gram-negative: E. coli, Pseudomonas)
- Fungal peritonitis (Candida) — often after antibiotic courses
- Mycobacterial / culture-negative peritonitis
Cloudy effluent — non-infectious
- Chemical/eosinophilic peritonitis (icodextrin, reaction to PD solution or tubing, eosinophils on differential)
- Chylous effluent; malignancy
- Hemoperitoneum (blood-tinged) — menstruation/ovulation, cyst rupture, anticoagulation, trauma
Abdominal pain in a PD patient (not always peritonitis)
- Constipation (common; treat with laxatives — can also cause outflow failure)
- Catheter-tip malposition / outflow obstruction; inflow pain
- Surgical abdomen, EPS (long PD vintage, especially after severe or recurrent peritonitis), pancreatitis
Examiner keywords
the words he waits for
🔎
Investigations & data
- Effluent cell count + differential — WBC >100/uL with >50% neutrophils supports peritonitis; in rapid-cycle APD use the percentage: >50% neutrophils strongly suggests peritonitis even if WBC <100/uL
- Effluent Gram stain and culture (blood-culture bottles; centrifuge to raise yield) — guides organism-specific therapy
- Peripheral blood cultures if systemically septic or immunosuppressed
- Exit-site swab if discharge; assess tunnel
- Effluent differential for eosinophils (chemical/eosinophilic) or RBCs (hemoperitoneum)
- If culture-negative and not improving: special cultures for mycobacteria/fungi, consider imaging
- Correct culture technique (ISPD 2022): bedside inoculation of 5-10 mL effluent into BOTH aerobic and anaerobic blood-culture bottles; specimen to the laboratory within 6 h; if delayed, incubate the bottles at 37 C — never refrigerate or freeze
- Large-volume method to cut the culture-negative rate: centrifuge 50 mL effluent at 3000 g for 15 min, resuspend the sediment in 3-5 mL supernatant and culture the pellet — raises yield 5-10 fold (ISPD 2022)
- No growth at day 3: repeat effluent cell count with differential PLUS special culture request for mycobacteria, Nocardia, filamentous fungi and other fastidious bacteria; subculture aerobic/anaerobic/microaerophilic for a further 3-4 days
- Send effluent for cell count and culture after any WET contamination even if the patient is asymptomatic (ISPD 2022)
| Finding | Interpretation |
|---|---|
| Cloudy fluid + WBC >100/uL, >50% neutrophils | Peritonitis (2 of 3 criteria — culture may still be pending) |
| Yeast on Gram stain / Candida on culture | Fungal peritonitis — remove catheter now + systemic antifungal |
| Multiple enteric organisms / fecal odour | Possible intra-abdominal source — urgent surgical review and anaerobic cover; the catheter is usually removed if laparotomy is needed |
| Eosinophils predominate, cultures negative | Eosinophilic/chemical peritonitis (icodextrin, reaction to PD solution or tubing) |
| Blood-stained effluent in a menstruating woman | Hemoperitoneum from menstruation/ovulation — usually self-limited |
| No improvement (still cloudy, WBC high) at day 5 | Refractory peritonitis — remove catheter (longer observation is acceptable only if the count is clearly falling toward normal) |
| New episode, SAME organism, within 4 weeks of the last dose of antibiotics | Relapsing (also counts if one of the two episodes was culture-negative) |
| New episode, DIFFERENT organism, within 4 weeks of the last dose | Recurrent — worse prognosis than relapsing |
| New episode, SAME organism, more than 4 weeks after the last dose | Repeat peritonitis |
| Peritonitis within 3 months of an exit-site/tunnel infection, same organism (or one site sterile on antibiotics) | Catheter-related peritonitis |
| Peritonitis criteria met but no organism grown | Culture-negative peritonitis — ISPD target is under 15% of all episodes |
| No growth at 72 h but effluent clearing | Likely Gram-positive; stop the Gram-negative agent and continue the Gram-positive agent already running alone, total duration 2 weeks (ISPD: the initial therapy is continued; Figure 10 example: gentamicin stopped, cefazolin IP continued for 14 days) |
| Unit culture-negative rate above 15% of episodes | Review sampling and culture technique first (ISPD 2022, 2C); also consider recent antibiotics and atypical organisms |
| Contamination with the clamp CLOSED, no fluid contact | Dry contamination — no prophylactic antibiotics |
| Contamination with fluid infused / set left open / clamp status unknown | Wet contamination — transfer-set change + effluent sample + prophylactic antibiotics |
Recent changes
what changed — say it-
My unit target is peritonitis no more than 0.4 per patient-year, with over 80 percent of patients peritonitis-free each year.ISPD 2022: peritonitis rate target <=0.40 episodes/patient-year, >80% peritonitis-free per year; oral NAC may mitigate aminoglycoside ototoxicity.
⚡
Immediate priorities
ordered
- Recognise a cloudy effluent as peritonitis until proven otherwise; assess for sepsis (ABC, vitals).
- Drain the dwell; send effluent cell count + differential, Gram stain, and culture in blood-culture bottles BEFORE antibiotics.
- Dry abdomen: instill ~1 L, dwell 2 h, then drain and sample.
- Start empiric IP vancomycin + ceftazidime (cover Gram-positive AND Gram-negative) right after sampling, without waiting for the cell count or culture.
- Consider IP heparin 500 U/L for cloudy effluent (may help prevent fibrin occlusion of the catheter); give analgesics as needed.
- Add antifungal prophylaxis with the antibiotic course (ISPD 2022, 1B) to prevent secondary fungal peritonitis.
- Examine the exit site and tunnel; look for a source (contamination, constipation, catheter).
- Fungal or refractory peritonitis -> remove the catheter (ISPD suggests removal for non-tuberculous mycobacterial peritonitis, 2D); relapsing/recurrent/repeat -> consider timely removal; fecal/enteric -> urgent surgical review.
- Decide admit vs treat at home (admit if fever, sepsis, significant pain or unable to do PD at home; otherwise a stable, trained patient -> home). Use the IP route unless there are features of systemic sepsis.
- Contamination call (no symptoms yet): classify WET vs DRY before anything else — wet (open system / fluid infused / set left open) needs a transfer-set change + effluent sample + prophylactic antibiotics; dry needs none. If unsure, treat as wet.
🧬
Why it happens
the mechanism behind the plan
- Antibiotics sterilise the effluent and can hide the organism → sample before antibiotics, using blood-culture bottles for yield.
- Intraperitoneal dosing gives high local concentration at the site of infection → vancomycin and ceftazidime cover Gram-positive and Gram-negative organisms.
- Fibrin can block the catheter → consider heparin in the bag to help prevent fibrin occlusion; catheter biofilm drives relapse → timely catheter removal for relapsing, recurrent, fungal or refractory infection.
- Treatment duration reflects the organism's virulence, and extending courses beyond that adds more repeat peritonitis and secondary fungal peritonitis without clear benefit → follow the ISPD duration per organism, avoiding prolonged aminoglycoside courses.